Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 47,455 full-time employees. The firm focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The firm focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The firm operates in Japan, the United States, Europe, and China.
Takeda Pharmaceutical Company Limited 'in CEO'su kimdir?
Mr. Christophe Weber 2014 'den beri şirketle birlikte olan Takeda Pharmaceutical Company Limited 'in President 'ıdır.
Takeda Pharmaceutical Company L hissesinin fiyat performansı nasıl?
Takeda Pharmaceutical Company L 'in mevcut fiyatı $16.68 'dir, son işlem günde 0% 下降 etti.
Takeda Pharmaceutical Company Limited için ana iş temaları veya sektörler nelerdir?
Takeda Pharmaceutical Company Limited Pharmaceuticals endüstrisine ait ve sektör Health Care 'dir
Takeda Pharmaceutical Company Limited 'in piyasa değerlemesi nedir?
Takeda Pharmaceutical Company Limited 'in mevcut piyasa değerlemesi $52.6B 'dir
Takeda Pharmaceutical Company Limited al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 16 analist Takeda Pharmaceutical Company Limited için analist derecelendirmeleri gerçekleştirdi, bunlar 3 güçlü al, 7 al, 8 tut, 0 sat ve 3 güçlü sat içermektedir